Details for New Drug Application (NDA): 079061
✉ Email this page to a colleague
NDA 079061 describes ALCLOMETASONE DIPROPIONATE, which is a drug marketed by Fougera Pharms, Glenmark Pharms Ltd, and Taro, and is included in six NDAs. It is available from three suppliers. Additional details are available on the ALCLOMETASONE DIPROPIONATE profile page.
The generic ingredient in ALCLOMETASONE DIPROPIONATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
The generic ingredient in ALCLOMETASONE DIPROPIONATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
Summary for 079061
| Tradename: | ALCLOMETASONE DIPROPIONATE |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | alclometasone dipropionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Jun 23, 2009 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
